HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults

The recruitment status of this study is unknown because the information has not been verified recently.

Verified March 2003 by NIH AIDS Clinical Trials Information Service.
Recruitment status was Active, not recruiting

Sponsor:

Information provided by:

NIH AIDS Clinical Trials Information Service

ClinicalTrials.gov Identifier:

NCT00013572

First received: March 21, 2001

Last updated: June 23, 2005

Last verified: March 2003

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

No publications provided by NIH AIDS Clinical Trials Information Service

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Eller MA, Slike BM, Cox JH, Lesho E, Wang Z, Currier JR, Darden JM, Polonis VR, Vahey MT, Peel S, Robb ML, Michael NL, Marovich MA. A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells. PLoS One. 2011;6(9):e24254. Epub 2011 Sep 16.

To Top